Home - CRI Chemometric imagingTime 2022-09-22 12:28:09
Web Name: Home - CRI Chemometric imaging
Coherent Raman Imaging
Label-free chemometric imaging for objective,
AI-assisted cell analysis and tissue diagnosis
CRI brings together ultra-fast fibre based lasers and Coherent Raman scattering microscopy to make high-speed truly label free imaging possible, scanning tumour tissue in seconds.
We are not currently raising funding from individual investors
Please be aware of any advisers purporting to be offering shares in the company.
The company is
in partnership with
Is your company interested
in CRI technology?
Let’s get in touch
The company has received grant funding from
The company is a spinout of
Latest on chemometric imaging
CRI raises £1.1 million to accelerate scale up
Cambridge Raman Imaging has raised £1.1 million through an equity funding round from existing and new investors, bringing CRI value at £6.1 million...
Cambridge Raman Imaging has been selected to coordinate a European Union grant to transform cancer diagnosis and treatment
Cambridge Raman Imaging (“CRI” or the “Company”) announces today it will coordinate a project selected to receive a €3.3 million grant in the...
<<< Thank you for your visit >>>